Physician profile
Thao Le
NPI 1467741298
$1,734.07
in general payments reported to CMS, 2019-2025
15 companies · $752 in 2025
The $752 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.97 · 2023: $251 · 2024: $711 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,714.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $679.98 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $319.43 | 2023-2025 | |
| Shockwave Medical, INC | $148.38 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Glaxosmithkline, LLC. | $123.46 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $112.86 | 2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.93 | 2023-2025 | Jardiance |
| Axsome Therapeutics, INC. | $41.97 | 2023-2025 | Auvelity |
| Novo Nordisk INC | $41.61 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.30 | 2025 | Xifaxan, Plenvu |
| Dexcom, INC. | $34.78 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $30.24 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $18.10 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.15 | 2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.48 | 2025 | Caplyta |
| Viiv Healthcare Company | $15.40 | 2025 | Apretude |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thao Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.